These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28663308)

  • 1. Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study.
    Chen YM; Huang WN; Wu YD; Lin CT; Chen YH; Chen DY; Hsieh TY
    Ann Rheum Dis; 2018 May; 77(5):780-782. PubMed ID: 28663308
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib.
    Wang ST; Tseng CW; Hsu CW; Tung CH; Huang KY; Lu MC; Lai NS
    Int J Rheum Dis; 2021 Nov; 24(11):1362-1369. PubMed ID: 34506078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.
    Urata Y; Uesato R; Tanaka D; Kowatari K; Nitobe T; Nakamura Y; Motomura S
    Mod Rheumatol; 2011 Feb; 21(1):16-23. PubMed ID: 20668905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.
    Curtis JR; Xie F; Yun H; Bernatsky S; Winthrop KL
    Ann Rheum Dis; 2016 Oct; 75(10):1843-7. PubMed ID: 27113415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report.
    Talotta R; Atzeni F; Sarzi Puttini P
    BMC Pharmacol Toxicol; 2016 Apr; 17():17. PubMed ID: 27098382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series.
    Serling-Boyd N; Mohareb AM; Kim AY; Hyle EP; Wallace ZS
    Ann Rheum Dis; 2021 Feb; 80(2):274-276. PubMed ID: 32732241
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
    Nakamura J; Nagashima T; Nagatani K; Yoshio T; Iwamoto M; Minota S
    Int J Rheum Dis; 2016 May; 19(5):470-5. PubMed ID: 24698305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.
    Mo YQ; Liang AQ; Ma JD; Chen LF; Zheng DH; Schumacher HR; Dai L
    BMC Musculoskelet Disord; 2014 Dec; 15():449. PubMed ID: 25532827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
    Kivitz AJ; Cohen S; Keystone E; van Vollenhoven RF; Haraoui B; Kaine J; Fan H; Connell CA; Bananis E; Takiya L; Fleischmann R
    Semin Arthritis Rheum; 2018 Dec; 48(3):406-415. PubMed ID: 30177460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept.
    Germanidis G; Hytiroglou P; Zakalka M; Settas L
    J Hepatol; 2012 Jun; 56(6):1420-1. PubMed ID: 22127282
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis.
    Rischin A; De Silva T; Le Marshall K
    Rheumatology (Oxford); 2019 Jun; 58(6):1111-1113. PubMed ID: 30753711
    [No Abstract]   [Full Text] [Related]  

  • 13. Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis.
    Maneiro JR; Souto A; Gomez-Reino JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):149-156. PubMed ID: 28284845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-related mortality in rheumatoid arthritis patients undergoing long-term low-dose glucocorticoid treatment: A population-based study.
    Yang SS; Hung CT; Li SF; Lee HM; Chung YC; Chen HH; Chang SC
    J Formos Med Assoc; 2018 Jul; 117(7):566-571. PubMed ID: 28882423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elderly-Onset Varicella Pneumonia in a Patient With Rheumatoid Arthritis Treated With Tofacitinib.
    Abe N; Kudo T; Jodo S
    Arthritis Rheumatol; 2018 Aug; 70(8):1233. PubMed ID: 29648682
    [No Abstract]   [Full Text] [Related]  

  • 16. Tofacitinib: raising awareness of mycoses.
    Dyer J; Morwood K; Choong K
    Intern Med J; 2019 Jun; 49(6):805-806. PubMed ID: 31185527
    [No Abstract]   [Full Text] [Related]  

  • 17. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.
    Li Z; An Y; Su H; Li X; Xu J; Zheng Y; Li G; Kwok K; Wang L; Wu Q
    Int J Rheum Dis; 2018 Feb; 21(2):402-414. PubMed ID: 29314645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, longterm extension studies.
    Wollenhaupt J; Silverfield J; Lee EB; Curtis JR; Wood SP; Soma K; Nduaka CI; Benda B; Gruben D; Nakamura H; Komuro Y; Zwillich SH; Wang L; Riese RJ
    J Rheumatol; 2014 May; 41(5):837-52. PubMed ID: 24692527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients: tofacitinib for the treatment of rheumatoid arthritis.
    Ann Intern Med; 2013 Aug; 159(4):I-26. PubMed ID: 24026272
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.